U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Lifitegrast

Last Revision: December 3, 2018.

Estimated reading time: 1 minute

CASRN: 1025967-78-5

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Breastmilk levels of lifitegrast have not been measured in humans. Because absorption from the eye is limited, ophthalmic lifitegrast would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Lifitegrast

CAS Registry Number

1025967-78-5

Drug Class

  • Breast Feeding
  • Lactation
  • Lymphocyte Function-Associated Antigen-1 Antagonist

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK500874PMID: 29999933

Views

Related information

Similar articles in PubMed

  • Review Loteprednol.[Drugs and Lactation Database (...]
    Review Loteprednol.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Rimexolone.[Drugs and Lactation Database (...]
    Review Rimexolone.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Levocabastine.[Drugs and Lactation Database (...]
    Review Levocabastine.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Bepotastine.[Drugs and Lactation Database (...]
    Review Bepotastine.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Olopatadine.[Drugs and Lactation Database (...]
    Review Olopatadine.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...